New BSACI Allergy Actions Plans for children available

The Paediatric Allergy Group (PAG) is pleased to announce the release of updated Allergy Action Plans for children at risk of anaphylaxis.

These revised plans are designed to function as Individual Healthcare Plans for children with food allergies, providing medical and parental consent for schools to administer medicines in the event of an allergic reaction. This includes consent to administer a “spare” back-up adrenaline auto-injector pen which schools are able to purchase under changes to the Human Medicines (Amendment) Regulations 2017, with effect from 1 October 2017.

The revised plans incorporate:

• space for parental and medical consent to administer medicines including “spare” adrenaline pens
• strengthening of the advice relating to body posture during anaphylaxis
• emphasis that anaphyalxis can occur without mild symptoms such as skin rash, and adrenaline auto-injectors
should be used BEFORE salbutamol to treat respiratory reactions
• fields to electronically complete Parent details, if desired

The revised plans are available at: https://www.bsaci.org/professional-resources/resources/paediatric-allergy-action-plans/